查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1496007

全球脑监测系统市场 – 2024 年至 2029 年预测

Global Brain Monitoring Systems Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 138 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

脑监测系统市场预计将以 8.03% 的复合年增长率成长，从 2022 年的 23.45 亿美元增至 2029 年的 40.27 亿美元。

在神经系统检查中，大脑监测系统用于识别脑细胞（神经元）功能异常，这些异常会导致帕金森氏症、癫痫、阿兹海默症、睡眠障碍等神经系统疾病的发生。这些技术可以监测和检测神经元活动，而无需进行侵入性脑部手术。监测脑外伤患者变得越来越重要，以避免进一步的脑损伤，特别是脑缺血。

在患者监测中评估颅内压升高 (ICP) 的需求日益增长，推动了对脑监测设备的需求。根据美国国家心理健康美国(NIMH) 2020 年的一项研究，四分之一的美国患有可诊断的精神疾病，约 6% 的人患有严重残疾。此外，同样的估计也显示，美国每年因严重精神疾病造成的总费用超过 3,170 亿美元。因此，市场在预测期内也可能成长。

脑监测市场竞争相对激烈，参与企业市场。就市场占有率而言，一些重要的公司现在在特定领域的分析市场中占据主导地位。然而，随着技术的进步和产品的突破，中小型公司正在透过提供新的​​、更易于使用的技术来增加其在市场上的影响力。

市场驱动因素：

  • 人口老化、脑部疾病盛行率的增加以及电子产品的便利性可能会推动市场成长。

创伤性脑损伤 (TBI) 是美国死亡和残疾的主要原因。 TBI 约占所有伤害死亡率的 30%。在美国，每天有 153 人死于包括 TBI 在内的伤害（资料来源：疾病美国与预防中心）。此外，由于生活环境的变化和压力水平的增加，医疗保健支出的增加和神经病变发病率的增加正在推动市场的成长。

此外，不断进步的技术进步为脑感测器的发展提供了机会，从而推动了预测期内全球脑监测设备的成长。此外，第一版脑电图监测仪充满了电缆和电极，今天的大多数设备仍然基于这种传统架构。然而，自从引入无线连接以来，使用脑电图监视器和其他相关设备的尺寸和难度已显着降低。

  • 设备技术创新的不断发展预计将增加对大脑监测系统的需求。

各种神经退化性疾病和神经系统疾病的盛行率不断上升，增加了行动脑电图设备、即时监测和警报的创新频率，这促进了对脑监测产品的需求。根据美国国家神经疾病和中风研究所的数据，仅在美国就有大约 3000 万人患有大约 7,000 种已确诊的罕见和超罕见疾病中的至少一种。超过45%的罕见疾病伴随神经系统症状。预计这些因素将激增对大脑监测产品的需求并推动市场发展。

此外，预计越来越多的大脑健康设备的监管核准将推动大脑监测系统市场的成长。一些医院和医疗机构正在将大脑植入植入神经病变风险的患者体内，以人为地控制大脑功能。此外，创新和先进的大脑健康设备的监管核准预计将在不久的将来推动市场成长。例如，2019 年 4 月，GE Healthcare 的新型 Revolution Apex电脑断层扫描器影像重建引擎获得了美国食品药物管理局510(k) 许可。

市场主要发展：

  • 2024 年 1 月—国家干细胞基金会 (NSCF) 将利用国际太空站的微重力环境来研究帕金森氏症和 PPMS 患者的脑类器官。这次任务是 NSCF 的第五次飞行，将收集有关大脑组织变化和发炎的资料。这些资料将为基金会的下一个任务提供讯息，其中包括从受影响患者身上采集的诱导性多功能干细胞的类器官。
  • 2022 年 11 月 - FDA核准Neurosteer 的单通道 EEG 大脑监测平台用于临床。该平台能够持续监测阿兹海默症、帕金森氏症和失智症疾病的无症状性认知能力下降。该平台还将有助于药物治疗的临床试验，并促进对神经退化患者进行具有成本效益的大批量筛检。较短的设定时间和机器学习功能可以客观、轻鬆地评估认知状态。
  • 2022 年 10 月 -Medtronic推出美敦力神经血管联合实验室 (TM)，这是一个针对中风治疗新概念的创新流程和平台。该平台收集并讨论医生、发明家、企业家和新兴企业改善中风护理的想法。我们的团队分析想法并选择最佳的投资于研究和原型开发。该平台还有助于将治疗方法推进到临床和商业阶段。
  • 2022 年 2 月 - Masimo 获得 FDA 批准用于 1-17 岁儿童患者的 SedLine® 脑功能监测和 SedLine 儿科脑电图感测器。将 SedLine 的潜在益处扩大到美国所有 1 岁以上患者，是提高最具挑战性和最年轻大脑患者护理品质的重要一步。 SedLine 使用先进的讯号处理技术来监测两侧的大脑活动，为临床医生提供大脑的整体情况，以帮助个人化 Sedangia 并侦测警讯。

公司产品

  • 双频指数 (TM) (BIS(TM)) 是一种监测技术，可增强临床医生以患者为导向的采用、维护和出现方法。 BIS(TM) 技术可非侵入性地测量和解释与麻醉剂效果直接相关的脑电波活动。
  • SedLine® 脑功能监测是一种大脑监测系统，可帮助临床医生监测麻醉下大脑的状态。取得双边资料和处理脑电图讯号有助于临床医生管理麻醉。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章全球脑监测系统市场：依产品类型

  • 介绍
  • 脑电图（EEG）
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 脑磁图（MEG）
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 磁振造影(MRI)
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 脑血氧计
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 其他的
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第六章全球脑监测系统市场：依应用分类

  • 介绍
  • 创伤性脑损伤 (TBI)
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 癫痫
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 阿兹海默症
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 其他的
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第七章全球脑监测系统市场：依最终用户分类

  • 介绍
  • 医院/诊所
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 神经中枢
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 学术研究所
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第八章全球脑监测系统市场：按地区划分

  • 介绍
  • 北美洲
    • 依产品类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 南美洲
    • 依产品类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 欧洲
    • 依产品类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 中东/非洲
    • 依产品类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 亚太地区
    • 依产品类型
    • 按用途
    • 按最终用户
    • 按国家/地区

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十章 公司简介

  • Compumedics Limited
  • GENERAL ELECTRIC COMPANY
  • Medtronic
  • Natus Medical Incorporated
  • NIHON KOHDEN CORPORATION
  • Tristan Technologies, Inc.
  • Masimo Corporation
  • Canon Medical Systems Corporation
  • CortiCare, Inc.
  • NeuroWave Systems Inc.
简介目录
Product Code: KSI061612145

The global brain monitoring systems market is projected to grow at a CAGR of 8.03% to reach US$4.027 billion by 2029, from US$2.345 billion in 2022.

In neurological testing, brain monitoring systems are used to identify any irregularity in the functionality of brain cells (neurons) that contributes to the development of neurological illnesses such as Parkinson's disease, epilepsy, Alzheimer's, and sleep problems. These technologies enable the monitoring and detection of neuronal activity without the need for invasive neurosurgery. Monitoring patients with traumatic brain injuries is becoming increasingly important to avoid further brain damage, especially cerebral ischemia.

The rising need for evaluating elevated intracranial pressure (ICP) in monitoring patients will drive demand for brain monitoring devices. According to the US National Institute of Mental Health (NIMH) 2020, one in every four American individuals has a diagnosable mental condition in any given year, with almost 6% having a severe disability. Additionally, according to the same estimate, the overall annual cost of serious mental illness in the United States surpasses USD 317 billion. Therefore, this would also lead the market to grow during the projected period.

The brain monitoring market is relatively competitive, with both large and small industry participants. In terms of market share, a small number of significant firms now dominate the market analyzed in certain areas. However, with technological improvements and product breakthroughs, mid-size to smaller businesses have increased their market presence by bringing new, more usable technologies.

Market Drivers:

  • Aging demographics, increased prevalence of brain illnesses, and gadget simplicity would propel the market growth.

In the United States, traumatic brain injury (TBI) is a leading cause of mortality and disability. TBIs account for around 30% of all injury mortality. Every day, 153 people in the United States die from injuries that include TBI (source: Centers for Disease Control and Prevention). In addition, rising healthcare expenditure and high incidences of neurological disorders due to changing living conditions and increasing stress levels are driving the market growth.

Furthermore, the growing technological advancements will provide an opportunity for the development of brain sensors, which will boost the growth of global brain monitoring devices in the forecast period. Moreover, the first versions of EEG monitors were filled with cables and electrodes, and even today, the great majority of devices are based on this traditional architecture. However, with the introduction of wireless connectivity, the size and awkwardness of EEG monitors and other associated equipment have been greatly decreased.

  • Rising Innovation in the devices is anticipated to increase the demand for brain monitoring systems.

The rising prevalence of various neurodegenerative and neurological disorders has led to an increased frequency of innovation in mobile EEG devices, real-time monitoring, and alarms, which is thus contributing to the demand for brain monitoring products. According to the National Institute of Neurological Disorders and Stroke, about 30 million people in the US alone suffer from at least one of the nearly 7,000 identified uncommon or ultra-rare disorders. More than 45% of uncommon diseases are associated with neurological symptoms. Factors like this are thus expected to surge the demand for brain monitoring products thus driving the market.

Furthermore, a rising number of regulatory approvals for brain health devices is projected to drive the global brain monitoring systems market growth. Several hospitals and healthcare organizations implement the insertion of brain implants in patients who are at risk of developing neurological disorders to provide artificial control on brain functioning. Additionally, regulatory approvals for innovative and advanced brain health devices are predicted to propel the market growth in the near future. For instance, in April 2019, GE Healthcare received the US Food and Drug Administration 510(k) clearance for its Deep Learning Image Reconstruction engine on the new Revolution Apex computed tomography device.

Market Key Developments:

  • January 2024- The National Stem Cell Foundation (NSCF) is using the International Space Station's microgravity environment to study brain organoids from patients with Parkinson's and PPMS. The mission, marking NSCF's fifth flight, is to collect data on tissue changes and inflammation in the brain. The data will inform the foundation's next mission, which will include organoids from induced pluripotent stem cells from affected patients. A follow-on investigation will be launched on SpaceX's 30th Commercial Resupply Services mission, including organoids from patients with Alzheimer's disease.
  • November 2022- The FDA approved the Neurosteer single-channel EEG brain monitoring platform for clinical use. This platform allows for continuous monitoring of presymptomatic cognitive decline in diseases like Alzheimer's, Parkinson's, and dementia. The platform can also aid in clinical trials for pharmaceutical therapeutics, facilitating cost-effective mass screening of neurodegenerative patients. The short set-up time and machine-learning features make it objective and easy to assess cognitive states. The portable and affordable EEG system is now widely available to all populations.
  • October 2022- Medtronic launched the Medtronic Neurovascular Co-Lab(TM), an innovation process and platform for new ideas in stroke care. The platform collects and examines ideas from doctors, inventors, entrepreneurs, and startups to improve stroke care. A team analyzes the ideas and expedites the best ones for investment in research or prototype development. The platform can also help shepherd therapies through clinical and commercial stages. It highlighted two big needs for innovation in stroke care: innovations to extend the window of care and discover ways to foster brain tissue regrowth.
  • February 2022- Masimo received FDA clearance for SedLine(R) brain function monitoring for pediatric patients aged 1-17 years and the SedLine Pediatric EEG Sensor. This expansion of SedLine's potential benefits to all patients one year old and above in the United States is a significant step towards improving the quality of care for patients with challenging and youngest brains. SedLine uses advanced signal processing technology to monitor brain activity bilaterally, providing clinicians with a more complete picture of the brain, helping to personalize sedoanalgesia and detect warning signs.

Company Products:

  • Bispectral Index(TM) (BIS(TM)) is a monitoring technique that enhances the clinician's patient-targeted approach to induction, maintenance, and emergence. BIS(TM) technology non-invasively measures and interprets the wave activity of the brain directly related to the effects of anesthetic agents.
  • SedLine(R) Brain Function Monitoring is a brain monitoring system that helps clinicians monitor the state of the brain under anesthesia. It acquires bilateral data and processes EEG signals that help clinicians with anesthetic management.

Segmentation:

By Product Type

  • Electroencephalography (EEG)
  • Magnetoencephalography (MEG)
  • Magnetic Resonance Imaging (MRI)
  • Cerebral Oximeters
  • Others

By Application

  • Traumatic Brain Injury (TBI)
  • Epilepsy
  • Alzheimer's Disease
  • Others

By End-user

  • Hospitals & Clinics
  • Neurological Centers
  • Academic and Research Institutes

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits for the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL BRAIN MONITORING SYSTEMS MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Electroencephalography (EEG)
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Magnetoencephalography (MEG)
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Magnetic Resonance Imaging (MRI)
    • 5.4.1. Market Opportunities and Trends
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Cerebral Oximeters
    • 5.5.1. Market Opportunities and Trends
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness
  • 5.6. Others
    • 5.6.1. Market Opportunities and Trends
    • 5.6.2. Growth Prospects
    • 5.6.3. Geographic Lucrativeness

6. GLOBAL BRAIN MONITORING SYSTEMS MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Traumatic Brain Injury (TBI)
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Epilepsy
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Alzheimer's Disease
    • 6.4.1. Market Opportunities and Trends
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness
  • 6.5. Others
    • 6.5.1. Market Opportunities and Trends
    • 6.5.2. Growth Prospects
    • 6.5.3. Geographic Lucrativeness

7. GLOBAL BRAIN MONITORING SYSTEMS MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals & Clinics
    • 7.2.1. Market Opportunities and Trends
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Neurological Centers
    • 7.3.1. Market Opportunities and Trends
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness
  • 7.4. Academic and Research Institutes
    • 7.4.1. Market Opportunities and Trends
    • 7.4.2. Growth Prospects
    • 7.4.3. Geographic Lucrativeness

8. GLOBAL BRAIN MONITORING SYSTEMS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
      • 8.2.4.1. USA
        • 8.2.4.1.1. Market Opportunities and Trends
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Opportunities and Trends
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Opportunities and Trends
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Product Type
    • 8.3.2. By Application
    • 8.3.3. By End User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Opportunities and Trends
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Opportunities and Trends
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Opportunities and Trends
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Product Type
    • 8.4.2. By Application
    • 8.4.3. By End User
    • 8.4.4. By Country
      • 8.4.4.1. Germany
        • 8.4.4.1.1. Market Opportunities and Trends
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. France
        • 8.4.4.2.1. Market Opportunities and Trends
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. United Kingdom
        • 8.4.4.3.1. Market Opportunities and Trends
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Spain
        • 8.4.4.4.1. Market Opportunities and Trends
        • 8.4.4.4.2. Growth Prospects
      • 8.4.4.5. Others
        • 8.4.4.5.1. Market Opportunities and Trends
        • 8.4.4.5.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Product Type
    • 8.5.2. By Application
    • 8.5.3. By End User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
        • 8.5.4.1.1. Market Opportunities and Trends
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. UAE
        • 8.5.4.2.1. Market Opportunities and Trends
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Others
        • 8.5.4.3.1. Market Opportunities and Trends
        • 8.5.4.3.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Product Type
    • 8.6.2. By Application
    • 8.6.3. By End User
    • 8.6.4. By Country
      • 8.6.4.1. China
        • 8.6.4.1.1. Market Opportunities and Trends
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. Japan
        • 8.6.4.2.1. Market Opportunities and Trends
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. South Korea
        • 8.6.4.3.1. Market Opportunities and Trends
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. India
        • 8.6.4.4.1. Market Opportunities and Trends
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Indonesia
        • 8.6.4.5.1. Market Opportunities and Trends
        • 8.6.4.5.2. Growth Prospects
      • 8.6.4.6. Thailand
        • 8.6.4.6.1. Market Opportunities and Trends
        • 8.6.4.6.2. Growth Prospects
      • 8.6.4.7. Others
        • 8.6.4.7.1. Market Opportunities and Trends
        • 8.6.4.7.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Compumedics Limited
  • 10.2. GENERAL ELECTRIC COMPANY
  • 10.3. Medtronic
  • 10.4. Natus Medical Incorporated
  • 10.5. NIHON KOHDEN CORPORATION
  • 10.6. Tristan Technologies, Inc.
  • 10.7. Masimo Corporation
  • 10.8. Canon Medical Systems Corporation
  • 10.9. CortiCare, Inc.
  • 10.10. NeuroWave Systems Inc.